Clinical Trials Logo

Dural Tear clinical trials

View clinical trials related to Dural Tear.

Filter by:
  • None
  • Page 1

NCT ID: NCT04794166 Recruiting - Clinical trials for Lumbar Spine Surgery

Symptom Prevalence and Severity in Lumbar Spine Surgery With and Without Dura Rupture

Start date: March 1, 2021
Phase:
Study type: Observational

The primary purpose of this study is to assess whether lumbar spine surgery patients with dura rupture differ in symptom prevalence and severity from other lumbar spine surgery patients in the early postoperative phase. This is in order to develop a symptom-specific mobilization algorithm (DURAMOB) that can be used to assess whether patients with dura rupture safe can be mobilized earlier after lumbar back surgery to prevent bed rest complications

NCT ID: NCT04145544 Completed - Clinical trials for Cerebrospinal Fluid Leak

A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.

NEOART
Start date: January 7, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of ArtiFascia® in comparison with commercially available dural substitutes in patients requiring Dural repair following neurosurgery. Patients with planned cranial neurosurgery can take part in this study. During the surgery the soft membrane that covers the brain (called dura) is likely to be cut and damaged. A damaged dura can cause a leakage of brain fluids (cerebrospinal fluid [CSF] leakage) and increase the risk of infections. Sponsor of this study has developed the ArtiFascia®. ArtiFascia® is a medical synthetic dural substitute that is absorbed by the body. ArtiFascia® supports the re-formation of a new dura. In addition it has a sealant layer that can reduce CSF leakage and infection.